Troy Combo
Program Manager, Aboriginal Health Plan, EC Australia
Working groups
Background
Troy Combo is a Program Manager at Burnet Institute and a highly regarded leader in Aboriginal health with over 30 years of experience spanning primary health care, workforce coordination, policy development and research.
A Bundjalung man from northern New South Wales, Troy brings a strong cultural lens and deep understanding of the health challenges impacting Aboriginal and Torres Strait Islander peoples and communities. His career has focused primarily on blood-borne viruses (BBVs) and sexually transmissible infections (STIs), combining epidemiology, systems thinking, surveillance, and innovative research methodologies to influence policy and service delivery at community, jurisdictional and national levels.
Troy leads the coordination of the Eliminate Hepatitis C Australia Partnership's (EC Australia), Aboriginal Health Program. Working in partnership with Aboriginal Community Controlled Organisations and local communities, he leads initiatives to promote access to hepatitis C testing, treatment and care, advancing holistic, culturally appropriate models of care, that support the prevention of hepatocellular carcinoma. His work extends to improving population level outcomes for vulnerable groups, including people who inject drugs and those in custodial settings.
Troy has held high level leadership positions in local, state and national Aboriginal Community Controlled Health Organisations. During his time at Bulgarr Ngaru Medical Aboriginal Corporation as Healthy for Life and Programs Manager, and Acting Executive Officer he managed a multidisciplinary team of health professionals across primary, allied, and specialist health services including ENT, chronic care, alcohol and other drugs, diabetes, hearing, maternal health, and immunisation programs.
Beyond his program management roles, Troy provides strategic advice on many leadership groups to improve health outcomes for Aboriginal people and enjoys event facilitation and MC’ing.
Qualifications
- 2014: Certificate IV in Mental Health
- 2005: Certificate IV Training and Assessment
- 1998: Certificate in Research and Evaluation, Macquarie University
Appointments
- 2015-2017 Human research Ethics Committee Northern and Mid North Coast of NSW
- 2016 -2019 School of Medicine Aboriginal & Torres Strait Islander Committee, Western Sydney University
- 2016 National Data Validation Working Group, Department of Health, Australian Government
- 2013 Board of Director, Gallang Place Aboriginal & Torres Strait Islander Corporation
- 2013 Affiliate, Australian Institute of Company Directors
- 2006 Scientific Committee, Australian research Centre in Sex Health and Society
- 2000 Member, The Australian College of Health Service Executives
Awards
- 2016: Excellence in Primary Health Care Awards, North Coast Primary Health Network
- 2005: Best Poster Presentation Social Research, Best Oral Presentation Indigenous Health, Australasian Society of HIV Medicine Conference 2005
Positions
- 2015 – 2020: Healthy for Life and Programs Manager & Acting Executive Officer, Bulgarr Ngaru Medical Aboriginal Corporation
- 2011 – 2015: SEWB Workforce Coordinator, Queensland Aboriginal Islander Health Council
- 2014 (secondment): National Telehealth Officer, National Aboriginal Community Controlled Health Organisation (NACCHO)
- 2013 (secondment): State Service Delivery Manager, Link-Up Queensland
Burnet publications
View 3 moreIt’s Your Right – implementation and outcomes of a co-designed national Australian hepatitis C health promotion campaign
International Journal of Drug Policy
Louisa Walsh et al
Systemic challenges for meaningful partnerships in Aboriginal and Torres Strait Islander health and medical research grant applications: a critical reflection
The Medical Journal of Australia
Heather McCormack, Troy Combo, Bridget Haire
Opportunities to improve surveillance of hepatocellular carcinoma in Australia
The Medical Journal of Australia
Jess Howell et al
Reports and other work
-
2024: Australia’s progress towards hepatitis C elimination annual report
2024: Australia’s progress towards hepatitis C elimination annual report -
2025: Australia’s progress towards hepatitis C elimination annual report
2025: Australia’s progress towards hepatitis C elimination annual report
Current projects
View 3 more
Methamphetamine and injecting drug use cohort studies: MIXMAX
MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies: SuperMIX and VMAX.
Injecting drug use in Melbourne: SuperMIX cohort study
The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).
Eliminate Hepatitis C Australia (EC Australia)
We're partnering to eliminate hepatitis C as a public health threat by 2030.
News and features
View 2 more
Honouring NAIDOC week: celebrating Indigenous research and leadership
Every Yarn Counts in Hepatitis C
NHMRC funding boost for hepatitis C elimination
Burnet will use the AUD$5 million to identify new ways of engaging the estimated 70,000 Australians living with Hepatitis C virus to receive care.